Line design

Abbreviated New Drug Applications and 505(b)(2) Applications

This chart tracks the date, drug, reference-listed company, applicant, and indications of publicly available drug launches resulting from Abbreviated New Drug Applications and 505(b)(2) Applications.

Reference Listed Drug ANDA Holder Generic Drug Name ANDA Applicant(s) Indication Launch Date
Ciprodex Sandoz ciprofloxacin / dexamethasone Upsher-Smith Used as ear drops to treat bacterial infections. 4/6/2026
Lumigan  AbbVie bimatoprost Amneal Used to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. 4/9/2026
ProAir HFA Teva albuterol Amneal Used to treat or prevent bronchospasm in patients 4 years of age and older with reversible obstructive airway disease, and for the prevention of exercise-induced bronchospasm in patients 4 years of age and older. 4/14/2026
QVAR  Teva beclomethasone dipropionate Amneal Used  for the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. 4/14/2026
Symbicort AstraZeneca budesonide / formoterol Teva Used to control symptoms of asthma and prevent symptoms such as wheezing in adults and children ages 6 and older. 5/27/2026
Januvia Merck sitagliptin Teva Used to lower blood sugar in adults with Type 2 diabetes. 5/28/2026
Januvia Merck sitagliptin Apotex Used to lower blood sugar in adults with Type 2 diabetes. 6/3/2026
Infuvite Adult Sandoz multivitamins Apotex Used  to prevent vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition 6/4/2026
Romidepsin Teva romidepsin Amneal Used to treat cutaneous T-cell lymphoma. 6/4/2026
Edarbi Azurity azilsartan Lupin Used to treat hypertension in adults to lower blood pressure. 6/17/2026
Solu-Cortef Pfizer hydrocortisone Apotex Used short-term for severe autoimmune or inflammatory conditions. 6/19/2026
Infuvite Pediatric Injection Sandoz multiple vitamins injection Apotex Used to prevent vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. 6/24/2026

GENERICally Speaking Hatch Waxman Bulletin

Jump to Page

Robins Kaplan LLP Cookie Preference Center

Your Privacy

When you visit our website, we use cookies on your browser to collect information. The information collected might relate to you, your preferences, or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. For more information about how we use Cookies, please see our Privacy Policy.

Strictly Necessary Cookies

Always Active

Necessary cookies enable core functionality such as security, network management, and accessibility. These cookies may only be disabled by changing your browser settings, but this may affect how the website functions.

Functional Cookies

Always Active

Some functions of the site require remembering user choices, for example your cookie preference, or keyword search highlighting. These do not store any personal information.

Form Submissions

Always Active

When submitting your data, for example on a contact form or event registration, a cookie might be used to monitor the state of your submission across pages.

Performance Cookies

Performance cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.

Powered by Firmseek
panfry31